Acquisition | MARINUS PHARMACEUTICALS INC | 11th February 2025

Initially announced on December 30, 2024 Immedica Pharma AB made a cash offer for MARINUS PHARMACEUTICALS INC of USD 0.55 per MARINUS PHARMACEUTICALS INC share held. Pending the completion of customary closing conditions, the Acquisition is expected to be completed on February 11, 2025. Trading in shares of MARINUS PHARMACEUTICALS INC is expected to be halted effective February 11, 2025.

The treatment below will be applied to the following indices:

• MARINUS PHARMACEUTICALS INC will be removed from the Index.
• The weight of MARINUS PHARMACEUTICALS INC (MRNS.OQ) based on its last close price will be distributed pro rata to remaining Index constituents.
• Effective Date (open): 11/02/2025

Solactive US Broad Market Index (GTR)
Solactive US Broad Market Index (PR)
Solactive US Extended Broad Market Index (GTR)
Solactive US Small Cap Index (GTR)
Solactive US Small Cap Index (PR)
Solactive US Small & Mid Cap Index (GTR)
Solactive US Small & Mid Cap Index (PR)